KRAS mutation was detected in three patients with NSCLC, whereas of the nine patients with SCCHN and available p16 results, six were positive for p16 expression by IHC, which is associated with human papillomavirus. This evidence concerns the gene KRAS and head and neck squamous cell carcinoma.